ArticleJournal of imaging informatics in medicine2026
A Spatiotemporal Transformer Framework on 4D-CT for Early Prediction of Progressive Pulmonary Fibrosis.
Article in Journal of imaging informatics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Progressive pulmonary fibrosis (PPF) remains difficult to predict because static imaging may not fully capture regional respiratory motion, ventilation heterogeneity, and mechanical deformation. We propose a spatiotemporal transformer (ST-Former) framework that jointly models dynamic lung deformation, ventilation, and regional strain from four-dimensional computed tomography (4D-CT). The model integrates CT intensity, deformable registration-derived displacement magnitude, Jacobian-based ventilation maps, and Green-Lagrange strain magnitude maps into a unified four-channel spatiotemporal representation across ten respiratory phases. A total of 210 subjects were included in the final analytic cohort, comprising 130 patients with progressive pulmonary fibrosis and 80 patients with non-progressive interstitial lung disease. Progression was defined using a multidisciplinary reference standard based on ≥ 10% relative decline in forced vital capacity within approximately 12 months and/or radiological worsening. Across patient-level fivefold cross-validation, ST-Former achieved an AUC of 0.947 ± 0.016, outperforming ConvLSTM-3D (0.902 ± 0.021) and 3D ResNet-50 (0.861 ± 0.027). The model also demonstrated improved calibration, with a Brier score of 0.067 and an expected calibration error of 0.028. Center-stratified and leave-one-center-out analyses were performed to assess robustness to institutional domain shift. These results suggest that motion-informed spatiotemporal learning may provide a promising imaging biomarker for predicting pulmonary fibrosis progression, although prospective external validation is required before clinical translation.
Indexed as
Identifiers
42274865What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.